| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |